Folegatti PM, Bittaye M, Flaxman A, et al. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. Lancet Infect Dis 2020; published online April 20. https://doi. org/10.1016/S1473-3099(20)30160-2—In this Article the spelling of Julia Marshall's name was incorrect. This correction has been made to the online version as of June 8, 2020, and will be made to the printed version.
. 2020 Jun 8;20(7):e148. doi: 10.1016/S1473-3099(20)30508-9
Correction to Lancet Infect Dis 2019; published online April 20. https://doi.org/10.1016/S1473-3099(20)30160-2
Issue date 2020 Jul.
© 2020 The Author(s). Published by Elsevier Ltd.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC7279718 PMID: 32526192